483 Baxter Pharmaceutical Solutions Sep 2012

483 Baxter Pharmaceutical Solutions Sep 2012

Larry Austin FDA, Sarah Napier FDA, Constantin Philopoulos FDA$119.00 - Available Now

FDA investigators audited the Baxter Pharmaceutical Solutions - Bloomington, IN, United States facility and issued inspectional observations (via FDA 483) on 27 Sep 2012.

Product details

  • Category: Human Drugs
  • Inspection end: 27 Sep 2012
  • Location: Bloomington, United States
  • FEI: 1000115571
Add To Cart